Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation

Transfusion

Volumn 48, Issue 11, 2008, Pages 2421-2428

  Kasbia, Gurnaam ^b   Al Gahtani, Farjah ^b   Tay, Jason ^b   Labonté, Laura ^b   Tinmouth, Alan ^b   Ramsay, Timothy ^b   Gillingham, Akira ^b   Yang, Lin ^b   Halpenny, Michael ^b   Giulivi, Antonio ^b   McDiarmid, Sheryl ^b   Huebsch, Lothar ^b   Allan, David S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; QUALITY OF LIFE; RISK FACTOR;

ADULT; ANEMIA; BLOOD CELL COUNT; CELL COUNT; ENDOTHELIAL CELLS; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 55349146597     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01876.x     Document Type: Article

References (24)

1. Bearman SI, Appelbaum FR, Buckner D, Petersen FB, Fisher LD, Clift RA, Thomas ED. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988 6 : 1562 8.
2. Grazzuitti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N, Fassas A, van Rhee F, Klaus H, Barlogie B, Anaissie EJ. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 2006 38 : 501 6.
3. Haynes SL, Wong JC, Torella F Dalrymple K, Pilsworth L, McCollum CN. The influence of homologous blood transfusion on immunity and clinical outcome in aortic surgery. Eur J Vasc Endovasc Surg 2001 22 : 244 50.
4. Avall A, Hyller M, Swollin B, Bengtson J, Carlsson L, Bengtsson A. Increased serum erythropoietin concentration after allogeneic compared with autologous blood. Transfusion 2002 27 : 203 10.
5. Weber EW, Slappendel R, Prins MH, van der Schaaf DB, Durieux ME, Strümper D. Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg 2005 1416 21.
6. Weber EW, Slappendel R, Hémon Y, Mahler S, Dalen T, Rouwet E, van Os J, Vosmaer A, van der Ark P. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005 22 : 249 57.
7. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital discharges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998 122 : 145 51.
8. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisier E the Transfusion Requirements in Critical Care Investigators, for The Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999 340 : 409 17.
9. Xenocostas A, Yee A, Wong CJ, Sutton DM, Lipton JH, Kiss TL, Messner HA. RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survival. Transfusion 2003 43 : 373 82.
10. Allan DS, Dubé P, Roy J, Busque L, Roy DC. Endothelial-like vascular progenitor cells from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors. Biol Blood Marrow Transplant 2007 13 : 433 9.
11. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007 213 : 341 7.
12. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 103 : 2776 9.
13. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathi T, Sher F. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005 36 : 151 3.
14. Gill M, Dias K, Hattori ML, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001 88 : 167 74.
15. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003 9 : 702 12.
16. Zinzani PL, Tani M, Alinari L, Molinari AL, Stefoni V, Visani G, Gentilini P, Guardigni L, Fina M, Baccarani M. Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. Leuk Lymphoma 2005 46 : 1449 54.
17. Allan DS, Keeney M, Popma J, Weir K, Bhatia M, Sutherland DR, Howson-Jan K, Chin-Yee IH. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002 29 : 967 72.
18. Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K, Shore TB, Walker IR, Browett P, Messner HA, Panzarella T, Lipton JH Canadian Bone Marrow Transplant Group. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002 100 : 1525 31.
19. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003 348 : 593 600.
20. Iqbal T, Rajagopal T, Halpenny M, Yang L, Martin L, Giulivi A, McDiarmid S, Huebsch L, Allan DS. Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation. Exp Hematol 2008 36 : 506 12.
21. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonoal analysis and hematopoietic stem/progenitor cell principals. Blood 2007 109 : 1801 9.
22. Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, Doetschman T. Vasculogenesis and angiogenesis in embryonic-stem-cell derived embryoid bodies. Development 1988 102 : 471 8.
23. Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J, Hwang KK, Oh S, Choi YJ, Chae IH, Oh BH, Choi YS, Walsh K, Park YB. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003 108 : 2918 25.
24. Blau CA. Erythropoietin in cancer: presumption of innocence? Stem Cells 2007 25 : 2094 7.